KR20050006237A
(ko)
*
|
2002-05-06 |
2005-01-15 |
버텍스 파마슈티칼스 인코포레이티드 |
티아디아졸 또는 옥사디아졸 및 jak 단백질 키나제억제제로서의 이들의 용도
|
US6974870B2
(en)
|
2002-06-06 |
2005-12-13 |
Boehringer Ingelheim Phamaceuticals, Inc. |
Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
|
EP1513516B1
(en)
|
2002-06-06 |
2008-12-03 |
Boehringer Ingelheim Pharmaceuticals Inc. |
SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
|
EP1535922A4
(en)
*
|
2002-07-11 |
2006-10-04 |
Takeda Pharmaceutical |
PYRROLOPYRIDINE DERIVATIVE AND ITS USE
|
AU2003246972A1
(en)
|
2002-08-06 |
2004-02-23 |
Astrazeneca Ab |
Condensed pyridines and pyrimidines with tie2 (tek) activity
|
IL154306A0
(en)
*
|
2003-02-05 |
2003-09-17 |
Rimonyx Pharmaceuticals Ltd |
Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
|
SE0300908D0
(sv)
|
2003-03-31 |
2003-03-31 |
Astrazeneca Ab |
Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
JP2007536301A
(ja)
|
2004-05-04 |
2007-12-13 |
エフ.ホフマン−ラ ロシュ アーゲー |
Ikk阻害剤としてのチエノピリダジン
|
MXPA06013250A
(es)
*
|
2004-05-14 |
2007-02-28 |
Abbott Lab |
Inhibidores de quinasa como agentes terapeuticos.
|
DE602005010698D1
(de)
|
2004-06-09 |
2008-12-11 |
Glaxo Group Ltd |
Pyrrolopyridinderivate
|
US7439246B2
(en)
|
2004-06-28 |
2008-10-21 |
Bristol-Myers Squibb Company |
Fused heterocyclic kinase inhibitors
|
US7173031B2
(en)
|
2004-06-28 |
2007-02-06 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
US7432373B2
(en)
|
2004-06-28 |
2008-10-07 |
Bristol-Meyers Squibb Company |
Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
|
WO2006010264A1
(en)
|
2004-07-30 |
2006-02-02 |
Methylgene, Inc. |
Inhibitors of vegf receptor and hgf receptor signaling
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
US7674822B2
(en)
|
2004-11-24 |
2010-03-09 |
Wyeth |
PTP1b inhibitors
|
US7875627B2
(en)
|
2004-12-07 |
2011-01-25 |
Abbott Laboratories |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
|
MX2007014616A
(es)
|
2005-05-20 |
2009-08-12 |
Methylgene Inc |
Inhibidores de señalizacion del receptor del factor a de crecimiento endotelial vascular y del receptor del factor de crecimiento de hepatocitos.
|
ES2473341T3
(es)
|
2005-05-20 |
2014-07-04 |
Methylgene Inc |
Inhibidores de la se�alizaci�n del receptor del VEGF y del receptor del HGF
|
DE102005061170A1
(de)
|
2005-12-21 |
2007-07-05 |
Bayer Healthcare Ag |
Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
|
DE102005061171A1
(de)
|
2005-12-21 |
2007-07-05 |
Bayer Healthcare Ag |
Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
|
ES2374455T3
(es)
|
2006-02-17 |
2012-02-16 |
Pfizer Limited |
Derivados de 3-deazapurinza como moduladores de tlr7.
|
WO2007115822A1
(en)
*
|
2006-04-07 |
2007-10-18 |
Develogen Aktiengesellschaft |
Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions
|
DK3421471T3
(da)
|
2006-04-25 |
2021-06-14 |
Astex Therapeutics Ltd |
Purin- og deazapurinderivater som farmaceutiske forbindelser
|
EP2029608A1
(en)
|
2006-06-06 |
2009-03-04 |
Boehringer Ingelheim International GmbH |
Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
|
DE102007019690A1
(de)
*
|
2007-04-26 |
2008-10-30 |
Bayer Healthcare Ag |
Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
|
DE102007019691A1
(de)
*
|
2007-04-26 |
2008-10-30 |
Bayer Healthcare Ag |
Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
|
DE102007027800A1
(de)
|
2007-06-16 |
2008-12-18 |
Bayer Healthcare Ag |
Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
|
MY150059A
(en)
|
2007-10-11 |
2013-11-29 |
Astrazeneca Ab |
Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors
|
GEP20125664B
(en)
|
2008-02-26 |
2012-10-10 |
Takeda Pharmaceuticals Co |
Condensed heterocyclic derivatives and application thereof
|
EP2262815A4
(en)
|
2008-03-05 |
2012-04-11 |
Methylgene Inc |
Inhibitors of protein intolerance activity
|
US8486953B2
(en)
|
2008-08-26 |
2013-07-16 |
Boehringer Ingelheim International Gmbh |
Thienopyrimidines for pharmaceutical compositions
|
WO2010151317A1
(en)
|
2009-06-22 |
2010-12-29 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
US9096518B2
(en)
|
2009-06-22 |
2015-08-04 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
JP5575274B2
(ja)
|
2010-02-26 |
2014-08-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
医薬組成物のためのmnkl/mnk2阻害活性を有する4−[シクロアルキルオキシ(ヘテロ)アリールアミノ]チエノ「2,3−d]ピリミジン
|
UY33241A
(es)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
|
BR112012021453A2
(pt)
|
2010-02-26 |
2017-02-21 |
Boehringer Ingelheim Int |
tienopirimidina, sua composição farmacêutica e seu uso
|
US8778931B2
(en)
|
2010-12-22 |
2014-07-15 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
EP2694056B1
(en)
|
2011-04-01 |
2019-10-16 |
AstraZeneca AB |
Therapeutic treatment
|
CA2841111A1
(en)
|
2011-07-08 |
2013-01-17 |
Novartis Ag |
Novel pyrrolo pyrimidine derivatives
|
WO2013079964A1
(en)
|
2011-11-30 |
2013-06-06 |
Astrazeneca Ab |
Combination treatment of cancer
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
PT2797416T
(pt)
|
2011-12-28 |
2017-10-23 |
Global Blood Therapeutics Inc |
Compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
|
FR2988722B1
(fr)
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
CN102702223A
(zh)
*
|
2012-05-28 |
2012-10-03 |
盛世泰科生物医药技术(苏州)有限公司 |
一种2-溴-4-氯噻吩并[3,2-c]吡啶的制备方法
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
MY180206A
(en)
|
2013-03-15 |
2020-11-25 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
CN105073728A
(zh)
|
2013-03-15 |
2015-11-18 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
AP2015008718A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
US9802900B2
(en)
|
2013-03-15 |
2017-10-31 |
Global Blood Therapeutics, Inc. |
Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
EA201992707A1
(ru)
|
2013-11-18 |
2020-06-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
BR112016011727A2
(pt)
|
2013-11-22 |
2017-08-08 |
CL BioSciences LLC |
Antagonistas de gastrina para o tratamento e prevenção de osteoporose
|
DK3102208T3
(da)
|
2014-02-07 |
2021-03-08 |
Global Blood Therapeutics Inc |
Krystallinsk polymorf af den frie base af 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyd
|
JP6713982B2
(ja)
|
2014-07-24 |
2020-06-24 |
ファイザー・インク |
ピラゾロピリミジン化合物
|
CU20170007A7
(es)
|
2014-08-06 |
2017-06-05 |
Pfizer |
Compuestos de imidazopiridazina
|
WO2016092556A1
(en)
|
2014-12-11 |
2016-06-16 |
Natco Pharma Limited |
7-(morpholinyl)-2-(n-piperazinyl) methyl thieno [2, 3-c] pyridine derivatives as anticancer drugs
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
MA43373A
(fr)
|
2015-12-04 |
2018-10-10 |
Global Blood Therapeutics Inc |
Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
|
AR108435A1
(es)
|
2016-05-12 |
2018-08-22 |
Global Blood Therapeutics Inc |
Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
|
US10154992B2
(en)
*
|
2016-07-12 |
2018-12-18 |
The Regents Of The University Of California |
Compounds and methods for treating HIV infection
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
EP3759109B1
(en)
|
2018-02-26 |
2023-08-30 |
Gilead Sciences, Inc. |
Substituted pyrrolizine compounds as hbv replication inhibitors
|
WO2020072377A1
(en)
|
2018-10-01 |
2020-04-09 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
BR112021008741A2
(pt)
|
2018-11-09 |
2021-08-10 |
Vivace Therapeutics, Inc. |
compostos bicíclicos
|
TW202039481A
(zh)
|
2018-12-21 |
2020-11-01 |
美商西建公司 |
Ripk2之噻吩并吡啶抑制劑
|
KR20220016456A
(ko)
|
2019-04-16 |
2022-02-09 |
비바체 테라퓨틱스, 인크. |
바이사이클릭 화합물
|